Menopause — twelve months without a period, average age 51 — is preceded by perimenopause: several years of erratic estrogen swings driving irregular cycles, hot flashes and night sweats (affecting ~75% of women), broken sleep, mood changes and brain fog. Hormone therapy is the most effective treatment for these symptoms, and modern analysis shows that for most healthy symptomatic women under 60 or within 10 years of menopause its benefits outweigh risks — a major revision of the post-2002 fear. Effective non-hormonal options exist (certain antidepressants, CBT, the newer fezolinetant). Long-term, falling estrogen accelerates bone loss and shifts cardiovascular risk, both manageable. Bleeding after menopause always needs assessment.
The mechanics of the transition
Menopause is dated retrospectively — twelve months after the final period, average age 51 (range roughly 45–55; earlier with smoking, some surgeries and chemotherapy; "premature" before 40 deserves its own medical work-up). The symptomatic years are mostly perimenopause, the run-up in which the ovaries' remaining follicles respond erratically: estrogen doesn't decline gracefully but swings — spiking and crashing around cycles that shorten, scatter, skip and flood — before settling low after the final period.
Those swings explain the symptom map better than "low estrogen" does. Estrogen-sensitive circuits in the hypothalamus lose their thermostat calibration (hot flashes and night sweats — sudden heat, flushing, sweat, sometimes palpitations, lasting minutes, affecting ~75% of women); sleep architecture fragments (sweats plus independent effects); mood becomes weather-prone, particularly in women with premenstrual or postnatal sensitivity histories; and brain fog — word-finding, concentration — is now a documented, usually temporary, feature of the transition rather than imagination. Add vaginal dryness and urinary change (the one symptom set that progresses rather than passes), joint aches, skin and hair shifts, and libido change, and the transition touches most systems that borrowed estrogen's services.
Treatment: the rehabilitated toolkit
Hormone therapy (HT/HRT) — estrogen (with progestogen whenever a uterus is present, to protect its lining) — remains the most effective treatment for flashes, sweats and the sleep and mood disruption downstream, and helps bone besides. The 2002-era fear and its correction are summarized in the FAQ; current professional consensus: for healthy, symptomatic women under 60 or within 10 years of menopause, benefits generally outweigh risks, with transdermal estrogen (patch/gel) avoiding the clot risk oral forms carry, and individual histories — breast cancer, clots, stroke, liver disease — adjudicated with a clinician. Duration is individualized, not capped by slogan.
Genitourinary symptoms deserve their own line: local vaginal estrogen (cream, tablet, ring) treats dryness and urinary symptoms with minimal absorption and is considered safe for most women long-term, including many advised against systemic HT.
Non-hormonal options with evidence: low-dose SSRIs/SNRIs (paroxetine, venlafaxine and kin) meaningfully reduce flashes; fezolinetant, the first of the neurokinin-antagonist class, targets the recalibrated thermostat directly with strong trial results; gabapentin helps night-dominant sweats; CBT for menopause improves how much symptoms interfere, with good trial support; clonidine trails the field. Practical scaffolding — layered clothing, cooling, trigger honesty (alcohol, spice, hot rooms), paced breathing — helps at the margins.
The supplement aisle — black cohosh, soy isoflavones, red clover and the "hormone balance" genre — is graded honestly in Do menopause supplements work?; the summary is modest-to-nothing, with placebo doing impressive work in flash trials.
The long game
Estrogen's departure has two structural bills: bone — loss accelerates sharply in the first post-menopausal years (screening, calcium/vitamin D adequacy, resistance and impact exercise, and treatment where risk scores earn it); and cardiovascular risk, which drifts toward male patterns (the standard levers — pressure, lipids, glucose, smoking — apply, with the weight-redistribution note from the FAQ). Neither is destiny; both reward the unglamorous program this site keeps recommending.
When to see a doctor
Book in for: symptoms interfering with life (treatment exists; enduring is optional), cycle chaos with flooding or cycles under 21 days, menopause signs before 45, or to plan HT suitability. Always and promptly for any bleeding after twelve period-free months — usually benign, always investigated — and for new breast changes. The transition itself is physiology; its miseries are treatable; and the woman who arrives with three months of tracked symptoms leaves with a plan faster than the one told to wait it out.
Frequently asked questions
How do I know I'm in perimenopause — is there a test?
Mostly by pattern, not blood: cycles shortening or scattering, new night sweats, sleep and mood shifts in the mid-40s tell the story, while hormone levels swing so wildly week to week that a single FSH or estrogen test can mislead (tests earn their place under 45, or when the picture confuses). Tracking three months of cycles and symptoms gives a doctor more than any single draw.
What did the 2002 scare get wrong — and what's the truth on HRT and breast cancer?
The Women's Health Initiative trial enrolled women averaging 63 — a decade-plus past menopause — and its risks were broadcast without that context. Re-analysis by age shows women starting near menopause fared well, and the absolute breast-cancer signal with combined HRT is small (roughly an extra case per 1,000 users per year, emerging after ~4–5 years; estrogen-only showed no increase in that trial). Risk framing now: for symptomatic women under 60, benefits generally outweigh risks; individual history still decides.
How long do hot flashes last?
Longer than the old reassurance: median duration is around 7 years, with a wide range — some women months, some into their 60s and beyond. Duration is not a treatment verdict either way; it is a reason not to white-knuckle years of misery when effective options exist.
Does menopause cause weight gain?
The transition redistributes more than it adds — estrogen's fall shifts storage abdominal even at stable weight — while aging's muscle loss slows metabolism in both sexes. The counters are unchanged: resistance training, protein emphasis, sleep repair. Abdominal gain plus energy dips also earns a glucose check, since the transition unmasks insulin resistance in some women.
References
- Office on Women's Health, U.S. Department of Health and Human Services. Menopause (2023). https://www.womenshealth.gov/menopause
- National Institute on Aging. Memory Problems, Forgetfulness, and Aging (2023). https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/memory-problems-forgetfulness-and-aging
This page contains no product recommendations or affiliate links. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.